Vessi Medical Revenue and Competitors

Vessi Medical is an Israeli medical device startup that brings a new approach to treat urological tissue. The Company uses surface cryotherapy, a treatment that utilizes extreme cold, to freeze and destroy abnormal tissue.\n\nTHE LEADING STANDARD OF CARE HAS NUMEROUS LIMITATIONS \nCurrent invasive surgical procedures, performed under general anaesthesia and requiring a costly hospital stay, can often be inadequate, with increased complications as patients need multiple repeat procedures that further reduce quality of life.\n\nVESSI PROVIDES A NEW, OFFICE-BASED THERAPY ALTERNATIVE TO SURGERY\nVessi's minimally invasive solution provides a new, office-based therapy alternative to surgery. The company's patent-pending, bladder-specific cryotherapy technology eliminates costly and problematic repeat surgeries. The technology successfully ablates unwanted tissue, reduces complications, all while causing no bladder damage. The Vessi system consists of a standalone console and a disposable catheter that is inserted into the bladder. \n\nCHANGING THE STANDARD OF CARE \nVessi is backed by the The Trendlines Group, Alive VC and a strategic partner, and led by seasoned medical device and cryotherapy veterans. The company has already demonstrated promising proof of concept in animals with its Alpha product. Vessi’s first application will initially target urological tissue treatments.\n\nFor more information, please email eyal@vessimed.com.